Novo Nordisk Denmark A/S

Novo Nordisk Denmark A/S (CVR number: 38180045) is a company from KØBENHAVN. The company reported a net sales of 2017.3 mDKK in 2023, demonstrating a growth of 295.6 % compared to the previous year. The operating profit percentage was at 5 % (EBIT: 101 mDKK), while net earnings were 82 mDKK. The profitability of the company measured by Return on Assets (ROA) was 13.6 %, which can be considered good but Return on Equity (ROE) was 111.7 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 8.2 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. Novo Nordisk Denmark A/S's liquidity measured by quick ratio was 1.1 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.